The significant differences in breast cancer patients were p = 0.0013 (IL-6) and p = 0.0026 (IL-8) compared to colorectal cancer patients and p < 0.0001 (IL-6) and p = 0.0004 (IL-8) compared to pancreatic patients. This evidence concerns the gene IL6 and breast carcinoma.